Status:
UNKNOWN
Therapeutic Follow-up of Antibiotics in Pediatric Intensive Care
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Intensive Care Units, Pediatric
Eligibility:
All Genders
Up to 18 years
Brief Summary
Currently, recommendations for antibiotic testing (ATS) in adult intensive care have been published. The 2018 SFAR and the Abdul- Aziz et al expert conference recommend routine testing for β-lactams, ...
Eligibility Criteria
Inclusion
- Any child hospitalized in the pediatric intensive care unit of the CHU Nord de La Réunion,
- Age is less than 18 years,
- Having started a curative antibiotic therapy by β-lactam, linezolid, vancomycin or aminosides.
- For whom a non-opposition has been collected orally from both or one of the child's legal guardians and from the child himself (if applicable),
- Covered by Social Security.
Exclusion
- Patients on prophylactic antibiotic therapy
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT05354635
Start Date
June 1 2022
End Date
June 1 2025
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Réunion
Saint-Denis, Reunion, 97400